- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2010
- Public Summary Document (PSD) November 2010 PBAC Meeting - PDF
Omalizumab (rch) – November 2010
Omalizumab (rch), powder for injection, 150 mg, Xolair®
Last updated
2 March 2011